2 models fit Entegris Inc. Common Stock and they disagree: 0 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
ACCE opinionEntegris Inc. Common Stock (ENTG)
Fair value (2 models)
$73.93
ACCE price target
$135
Rating
Overvalued
Horizon
12 months
Fair value published on 23 Oct 2026, 10:03 CEST; previously $80.27 since 18 Oct 2026, 17:04 CEST.
ACCE price target published on 25 Sept 2026, 00:00 CEST.
Rating published on 18 Oct 2026, 17:04 CEST.
Price used: $135 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison and EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
82.0% above
-45.0% to fair value
ACCE score
54
out of 100
Analysts
80% buy
15 covering
P/E
67.3x
forward 26.4x
1-year return
+48.2%
Dividend yield
0.31%
Entegris Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Entegris makes specialty materials and filtration products that semiconductor fabs consume in every wafer process: high-purity chemicals and gases, wafer carriers, and filters that keep contamination out of advanced-node lines. The moat is qualification, since chipmakers spend long periods validating a supplier before swapping it out, which gives Entegris sticky, recurring consumable revenue. Revenue is growing 11.5% and gross margin sits at 45.6%, with operating margin at 19.3%, which is healthy for a materials business. The stock trades at 80x trailing earnings but 31.8x forward, so the market is pricing in a meaningful earnings recovery from a cyclical trough. Whether that recovery arrives on schedule, with ROE still only 7.7%, is the question to answer before going further.